GBM, currently recognized as an isocitrate dehydrogenase (IDH) wild type WHO grade 4 diffuse gliomas, is a primary brain tumor affecting adults and having one of the lowest survival rates despite the current standard of care being applied as early as possible [3–5]. The gene discussed is IDH1; the disease is glioblastoma.